Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 1Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroblastoma 1Lymphoma, Large-Cell, Anaplastic 1Leukemia 1

Interventions

Cyclophosphamide 5Melphalan 4Isotretinoin 4Etoposide 4Carboplatin 4Vincristine 3Therapeutics 3Radiotherapy 3Cisplatin 3Topotecan 2Stem Cell Transplantation 2Radiotherapy, Image-Guided 2Psychiatric Rehabilitation 2Granulocyte-Macrophage Colony-Stimulating Factor 2Granulocyte Colony-Stimulating Factor 2Doxorubicin 2Dexamethasone 2Calcium Dobesilate 2Busulfan 2Blood Specimen Collection 2Aprepitant 23-Iodobenzylguanidine 2sargramostim 1pegfilgrastim 1humanized 3F8 anti-GD2 monoclonal antibody 1hetrombopag 1etoposide phosphate 1dexamethasone acetate 1dexamethasone 21-phosphate 1Whole-Body Irradiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Neuroblastoma × Vindesine × Clear all
NCT00526318 2015-07-16

Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma

National Cancer Institute (NCI)

Phase NA Unknown
360 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡